William L. Greene

Dr. Greene has been Iconic Therapeutics’ CEO and a Director since 2014, bringing 20 years as an operating executive, clinician, investor, and entrepreneur. He joined from MPM Capital, where he was Managing Director and an Investment Committee member, leading investments and serving on Boards of emerging biopharmaceutical and medical device companies.

Previously, Dr. Greene was a Senior Clinical Scientist and Epidemiologist at Genentech, responsible for clinical strategy, trial design and execution, and regulatory interactions in several therapeutic areas at all development stages, including leading the early clinical development of Lucentis®. Before that, he was a Resident in Internal Medicine and Diagnostic Radiology at Yale, and an Assistant Professor of Medicine at UCSF.

Dr. Greene received his B.A. from Wesleyan University and an M.D. from UCSF. He was a Robert Wood Johnson Clinical Scholar at Yale (clinical epidemiology) and a Howard Hughes Medical Institute Research Scholar at the NIH (neurobiology). He’s co-founder of and Senior Advisor to Pear Therapeutics and a long-standing advisor to the Bill and Melinda Gates Foundation, Worldmedicalguide. He’s the founding Chairman of the Board and head of the Investment Committee of the Global Health Investment Fund, the largest impact-oriented life science venture capital fund devoted to global health.